De Novo Splice‐Site Variant in DKC1 in a Female With Clinical Features of Hoyeraal–Hreidarsson Syndrome
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64097 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Dominique Braun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Dyskeratosis Congenita, Fetal Growth Retardation, Intellectual Disability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
The dyskerin encoding gene DKC1 plays an important role in telomerase activity and telomere maintenance. Pathogenic variants in DKC1 cause an X‐linked multiorgan disease called dyskeratosis congenita (DC), the most severe form of which is Hoyeraal–Hreidarsson syndrome (HHS). HHS due to DKC1 variants has so far only been reported in hemizygous males and is associated with severe neurological impairment and progressive bone marrow failure, often causing lethality in early childhood. Heterozygous carrier females are often phenotypically normal. Here, we report a young adult female carrying a de novo splice‐site variant in DKC1 and presenting with clinical features overlapping with HHS, such as intrauterine and postnatal growth retardation, microcephaly, intellectual disability, and recurrent infections, while lacking other typical aspects such as dermatological manifestations, cerebellar hypoplasia, or bone marrow failure. Aberrant splicing was confirmed with an in vitro assay, and further analysis revealed very short telomere lengths in the individual, supporting a causative role of the DKC1 variant. Our observations therefore suggest that heterozygous splice‐site variants in DKC1 leading to loss of function might result in a phenotype overlapping with but not being typical for HHS in females, supporting a potential genotype–phenotype correlation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Inselspital Bern, University of Bern, Bern, Switzerland.
- Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
- Clinic for Hematology and Oncology, Hirslanden Zürich, Zurich, Switzerland.
- Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
ORCID-Profile: Christiane Zweier
Zitieren
APA
Braun, D., Gregor, A., Haubitz, M., Baerlocher, G. M., Kraus, C., Rieubland, C., & Zweier, C. (2025). De Novo Splice‐Site Variant in DKC1 in a Female With Clinical Features of Hoyeraal–Hreidarsson Syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64097
Vancouver
Braun D, Gregor A, Haubitz M, Baerlocher GM, Kraus C, Rieubland C, et al. De Novo Splice‐Site Variant in DKC1 in a Female With Clinical Features of Hoyeraal–Hreidarsson Syndrome. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64097
BibTeX
@article{Braun2025,
author = {Braun, Dominique and Gregor, Anne and Haubitz, Monika and Baerlocher, Gabriela M and Kraus, Cornelia and Rieubland, Claudine and Zweier, Christiane},
title = {De Novo Splice‐Site Variant in DKC1 in a Female With Clinical Features of Hoyeraal–Hreidarsson Syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64097}
}
EUVIMED